Celularity (CELUW) FCF Margin (2020 - 2025)

Celularity (CELUW) reported FCF Margin of 124.34% for Q4 2025, down 34280.0% year-over-year from N/an in Q4 2024, and down 57.98% quarter-over-quarter from 78.71% in Q3 2025.

Celularity (CELUW) FCF Margin (2020 - 2025) Analysis & Trends

Celularity (CELUW) has 6 years of FCF Margin data on file, last reported at 124.34% in Q4 2025.

  • FCF Margin for Q4 2025 came in at 124.34%, down 34280.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 49.92% (down 3208.0% YoY), and the FY2025 annual result was 49.92%, down 3782.0% from the prior year.
  • FCF Margin fell to 124.34% in Q4 2025 per CELUW's latest filing, from 78.71% in the prior quarter.
  • Over five years, FCF Margin peaked at 218.46% in Q4 2024 and troughed at 1011.57% in Q2 2022.
  • A 5-year average of 348.8% and a median of 274.76% in 2023 frame the typical range for FCF Margin.
  • The sharpest annual moves came in 2021 and 2022: FCF Margin jumped 104262 bps in 2021, then tumbled 63383 bps in 2022.
  • A 5-year view of FCF Margin shows it stood at 754.67% in 2021, then gained by 17 bps to 625.12% in 2022, then jumped by 94 bps to 38.28% in 2023, then jumped by 671 bps to 218.46% in 2024, then tumbled by 157 bps to 124.34% in 2025.
  • Business Quant data shows CELUW's FCF Margin at 124.34% in Q4 2025, 78.71% in Q3 2025, and 17.42% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -3.98%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 43.35%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Celularity - - -3.27 Mn -124.34%

Historic Data

Download Data
DateValue
Dec 31, 2025 -124.34%
Sep 30, 2025 -78.71%
Jun 30, 2025 -17.42%
Mar 31, 2025 -26.19%
Dec 31, 2024 218.46%
Sep 30, 2024 -1.55%
Jun 30, 2024 -28.96%
Mar 31, 2024 -30.07%
Dec 31, 2023 -38.28%
Sep 30, 2023 -233.33%
Jun 30, 2023 -376.38%
Mar 31, 2023 -386.38%
Dec 31, 2022 -625.12%
Sep 30, 2022 -950.01%
Jun 30, 2022 -1,011.57%
Mar 31, 2022 -594.24%
Dec 31, 2021 -754.67%
Sep 30, 2021 -316.18%
Jun 30, 2021 -647.48%
Mar 31, 2021 -953.65%